Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05304390 · ClinicalTrials.gov registry record · NA
A Tailored Screening and Smoking Cessation Program for the LGBTQ Community of Seattle
A NA study, sponsored by Fred Hutchinson Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT05304390: Clinical Trial NA study, sponsored by Fred Hutchinson Cancer Center.
NCT05304390 is a NA study that was terminated before completion, run by Fred Hutchinson Cancer Center. The registered enrollment target is 53 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05304390, a NA study, was terminated before completion, sponsored by Fred Hutchinson Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
This clinical trial develops a tailored screening and smoking cessation program for the lesbian, gay, bisexual, transgender (trans) and queer (LGBTQ) community of Seattle, Washington. A lung cancer screening program may help LGTBQ people who smoke overcome unique barriers that keep them from receiving preventive care, and constantly facing healthcare discrimination. Members of the LGBTQ community have historically smoked at higher rates than the general population and thus could benefit greatly from targeted efforts to improve lung cancer screening and smoking cessation implementation.
Interventions
- BEHAVIORAL Smoking Cessation Intervention
- OTHER Questionnaire Administration
- BEHAVIORAL Patient Navigation
- PROCEDURE Carbon Monoxide Measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2022-06-06 |
| Est. Completion | 2024-10-28 |
| Phase | NA |
Why NCT05304390 stopped before completion
NCT05304390 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 4 interventions - of which Smoking Cessation Intervention is the first listed.
NCT05304390 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05304390 about?
NCT05304390 is a clinical study titled "A Tailored Screening and Smoking Cessation Program for the LGBTQ Community of Seattle". This clinical trial develops a tailored screening and smoking cessation program for the lesbian, gay, bisexual, transgender (trans) and queer (LGBTQ) community of Seattle, Washington. A lung cancer screening program may help LGTBQ people who smoke overcome unique barriers that keep them from receivi...
What is the current status of trial NCT05304390?
This trial is currently terminated. It is a NA study. The enrollment target is 53 participants. The study started on 2022-06-06. Estimated completion is 2024-10-28.
What interventions are being tested in trial NCT05304390?
The interventions under investigation include: Smoking Cessation Intervention (BEHAVIORAL), Questionnaire Administration (OTHER), Patient Navigation (BEHAVIORAL), Carbon Monoxide Measurement (PROCEDURE).
Who is sponsoring clinical trial NCT05304390?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05304390's enrollment target sits among peer trials
53 1271st of 2000 higher than 729 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI